Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
or

Sage Therapeutic Com (SAGE)

Sage Therapeutic Com (SAGE)
7.86 -0.09 (-1.13%) 04/01/25 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime 7.86 unch (unch) 16:02 ET
Quote Overview for Tue, Apr 1st, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
7.72
Day High
7.96
Open 7.96
Previous Close 7.95 7.95
Volume 1,305,200 1,305,200
Avg Vol 1,244,445 1,244,445
Stochastic %K 44.01% 44.01%
Weighted Alpha -40.78 -40.78
5-Day Change -0.67 (-7.85%) -0.67 (-7.85%)
52-Week Range 4.62 - 17.79 4.62 - 17.79
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 488,774
  • Shares Outstanding, K 61,481
  • Annual Sales, $ 41,240 K
  • Annual Income, $ -400,670 K
  • EBIT $ -411 M
  • EBITDA $ -416 M
  • 60-Month Beta 0.82
  • Price/Sales 12.34
  • Price/Cash Flow N/A
  • Price/Book 1.09

Options Overview Details

View History
  • Implied Volatility 80.38% ( -7.54%)
  • Historical Volatility 36.48%
  • IV Percentile 47%
  • IV Rank 30.18%
  • IV High 160.91% on 11/19/24
  • IV Low 45.56% on 01/15/25
  • Put/Call Vol Ratio 0.05
  • Today's Volume 118
  • Volume Avg (30-Day) 439
  • Put/Call OI Ratio 0.35
  • Today's Open Interest 13,744
  • Open Int (30-Day) 15,154

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 18 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -1.00
  • Number of Estimates 10
  • High Estimate -0.56
  • Low Estimate -1.24
  • Prior Year -1.80
  • Growth Rate Est. (year over year) +44.44%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.98 +12.61%
on 03/11/25
Period Open: 7.30
8.81 -10.78%
on 03/28/25
+0.56 (+7.67%)
since 02/28/25
3-Month
5.40 +45.52%
on 01/02/25
Period Open: 5.43
8.81 -10.78%
on 03/28/25
+2.43 (+44.75%)
since 12/31/24
52-Week
4.62 +70.13%
on 11/20/24
Period Open: 17.90
17.79 -55.82%
on 04/02/24
-10.04 (-56.09%)
since 04/01/24

Most Recent Stories

More News
Biogen Rises On FDA Nod for Alzheimer's Drug Dosing Regimen, But Sage Deal Fallout Irks Retail

The small-cap biotech firm called the proposal "significantly undervaluing" the company and added that it was not in the best interest of its shareholders.

SAGE : 7.86 (-1.13%)
QLV : 65.83 (-0.13%)
XBI : 78.16 (-3.63%)
BIIB : 132.03 (-3.52%)
Sage Therapeutics Stock Eyes Best Day In 5 Years On Biogen’s Unsolicited Bid: Retail Piles In

The two companies have collaborated since 2020 on the depression drug Zurzuvae, approved in 2023 by the FDA for treating postpartum depression.

SAGE : 7.86 (-1.13%)
BIIB : 132.03 (-3.52%)
SAGE's Dalzanemdor Fails to Meet Goal in Huntington's Disease Study

Sage Therapeutics’ SAGE phase II study evaluating its neuropsychiatric candidate, dalzanemdor (SAGE-718), for treating cognitive impairment (CI) associated with Huntington’s Disease (HD) failed to...

IMCR : 28.63 (-3.51%)
CSTL : 19.78 (-1.20%)
SAGE : 7.86 (-1.13%)
SPRO : 0.6940 (-3.61%)
Stocks Close Lower as Bond Yields Climb

The S&P 500 Index ($SPX ) (SPY ) Wednesday closed down -0.74%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -1.06%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.70%. US stock...

$SPX : 5,633.07 (+0.38%)
SPY : 560.97 (+0.28%)
$DOWI : 41,989.96 (-0.03%)
DIA : 419.59 (-0.07%)
$IUXX : 19,436.42 (+0.82%)
QQQ : 472.70 (+0.81%)
ZNM25 : 111-165 (-0.24%)
AAL : 10.30 (-2.37%)
LUV : 31.59 (-5.93%)
ALK : 49.04 (-0.37%)
CNC : 60.45 (-0.43%)
MOH : 327.71 (-0.51%)
Stocks Slide on Higher Bond Yields

The S&P 500 Index ($SPX ) (SPY ) today is down -0.51%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.81%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.36%. US stock indexes today are...

$SPX : 5,633.07 (+0.38%)
SPY : 560.97 (+0.28%)
$DOWI : 41,989.96 (-0.03%)
DIA : 419.59 (-0.07%)
$IUXX : 19,436.42 (+0.82%)
QQQ : 472.70 (+0.81%)
ZNM25 : 111-165 (-0.24%)
AAL : 10.30 (-2.37%)
UAL : 68.20 (-1.23%)
DAL : 42.42 (-2.71%)
LUV : 31.59 (-5.93%)
CNC : 60.45 (-0.43%)
Stocks Tumble on Concern Interest Rates Will Stay Higher for Longer

The S&P 500 Index ($SPX ) (SPY ) today is down -0.62%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.88%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.50%. US stock indexes today are...

$SPX : 5,633.07 (+0.38%)
SPY : 560.97 (+0.28%)
$DOWI : 41,989.96 (-0.03%)
DIA : 419.59 (-0.07%)
$IUXX : 19,436.42 (+0.82%)
QQQ : 472.70 (+0.81%)
ZNM25 : 111-165 (-0.24%)
AAL : 10.30 (-2.37%)
UAL : 68.20 (-1.23%)
DAL : 42.42 (-2.71%)
LUV : 31.59 (-5.93%)
OZK : 43.38 (-0.16%)
Why Sage Therapeutics Stock Sank Today

A secondary stock sale and underwhelming quarterly results sent investors to the off-ramp.

SAGE : 7.86 (-1.13%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sage Therapeutics, Inc. - SAGE

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Sage Therapeutics, Inc. ("Sage" or the "Company") (NASDAQ: SAGE). Such...

SAGE : 7.86 (-1.13%)
Is Sage Therapeutics Stock in Trouble After Dropping 50% in a Month?

The pharmaceutical company's growth prospects have taken a big hit.

BIIB : 132.03 (-3.52%)
SAGE : 7.86 (-1.13%)
SAGE INVESTIGATION NOTICE: Robbins Geller Rudman & Dowd LLP Announces Investigation into Sage Therapeutics, Inc. and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm

/PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving Sage...

SAGE : 7.86 (-1.13%)

Business Summary

SAGE Therapeutics Inc. is a biopharmaceutical company developing and commercializing medicines to treat life-threatening central nervous system (CNS) disorders. The Company provides treatments for schizophrenia, major depressive disorder, pain, and traumatic brain injury conditions. Its initial product...

See More

Key Turning Points

3rd Resistance Point 8.21
2nd Resistance Point 8.09
1st Resistance Point 7.97
Last Price 7.86
1st Support Level 7.73
2nd Support Level 7.61
3rd Support Level 7.49

See More

52-Week High 17.79
Fibonacci 61.8% 12.76
Fibonacci 50% 11.20
Fibonacci 38.2% 9.65
Last Price 7.86
52-Week Low 4.62

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trading Volatility: How to Use IV Rank & Percentile for Smarter Options Strategies